EU approves AZ's Imfinzi plus chemo for advanced biliary tract cancer AstraZeneca’s (AZ) Imfinzi (durvalumab) has been approved in the European Union (EU) as first-line treatment of adult patients ...
Today's top stock market movers. See the gainers and losers of the day including price action, trading volume and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback